Investigation Announcement for Tandem Diabetes Care, Inc.
Law Offices of Howard G. Smith is actively investigating on behalf of investors of Tandem Diabetes Care, Inc. regarding potential violations of federal securities laws that may have occurred. The focus of this investigation centers on the company's recent disclosures that could impact both operations and stock performance.
Understanding the Situation
It's important to delve into what actually happened. Recently, it was made public that Tandem had identified a significant malfunction within some of its insulin pumps. This malfunction posed a serious risk; it could trigger an error that halts insulin delivery, leading to hyperglycemia, a condition that may necessitate hospitalization or medical intervention for those affected.
Impact on Stock Value
Upon the announcement of this concerning news, Tandem's stock price experienced a notable decline. On the day of the revelation, the stock price fell by $2.87, which was a staggering 19.9% drop, leading to a closing price of $11.52 per share. This significant decrease has understandably alarmed current and potential investors.
The Importance of Legal Representation
If you are an investor who has suffered losses due to the recent events surrounding Tandem Diabetes Care, it's crucial to seek experienced legal advice. Contacting the Law Offices of Howard G. Smith can help you understand your legal rights and options for potentially recovering losses incurred.
Considering Your Legal Options
Investors should not remain passive in light of such alarming news. Engaging with legal experts can provide insight on how to navigate the complexities of securities law and help reinforce your position as a stakeholder.
Steps to Take for Affected Investors
If you have purchased shares in Tandem, now is the time to gather any information, understand your rights, and consider pursuing potential claims against the company. If you have any questions regarding your involvement or rights in this matter, it is advisable to reach out for legal assistance.
Contact Information
The Law Offices of Howard G. Smith can be contacted at the following address for anyone wishing to learn more about their options:
Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Telephone: (215) 638-4847,
Email: howardsmith@howardsmithlaw.com
Frequently Asked Questions
What prompted the investigation into Tandem Diabetes Care, Inc.?
The investigation was initiated due to a malfunction in some insulin pumps that could cause serious health risks and potentially violate federal securities laws.
How did the announcement affect Tandem's stock price?
The stock price fell by $2.87, or about 19.9%, on the day the malfunction was disclosed, closing at $11.52 per share.
What should affected investors do?
Affected investors should seek legal counsel to explore options for pursuing claims and recovering losses incurred due to the company’s disclosures.
Who can investors contact for legal questions?
Investors can reach out to the Law Offices of Howard G. Smith at the provided contact details for questions about their rights and possible claims.
Is there a risk of hospitalization due to the malfunction?
Yes, the malfunction can lead to a cessation of insulin delivery, potentially resulting in hyperglycemia, which may require urgent medical attention.
